Lyons, Hannah S.
Sassani, Matilde http://orcid.org/0000-0002-0384-7296
Hyder, Yousef
Mitchell, James L.
Thaller, Mark
Mollan, Susan P. http://orcid.org/0000-0002-6314-4437
Sinclair, Alexandra J. http://orcid.org/0000-0003-2777-5132
Sinclair, Alexandra
Finch, Aliza
Hampshire, Adam
Sitch, Alice
Mazaheri, Ali
Bagshaw, Andrew
Palmer, Andy
Strom, Asha
Waitt, Alice
Yiangou, Andreas
Abdel-Hay, Ahmed
Bennett, Alexander
Clark, Amy
Hunter, Angus
Seemungal, Barry
Witton, Caroline
Dooley, Caroline
Bird, Deborah
Fernandez-Espejo, Davinia
Smith, Dave
Ford, Dan
Sherwood, Daniel
Holding, Donna
Wilson, Duncan
Palmer, Edward
Golding, John
Dehghani, Hamid
Park, Hyojin
Lyons, Hannah
Smith, Hazel
Brunger, Helen
Ellis, Henrietta
Idrees, Iman
Varley, Ian
Hubbard, Jessica
Cao, Jun
Deeks, Jon
Mitchell, James
Novak, Jan
Pringle, Jamie
Terry, John
Rogers, Jack
Read, Tim
Fildes, Jessikah
Mullinger, Karen
Hill, Lisa
Aurisicchio, Marco
Thaller, Mark
Wilson, Martin
Pearce, Mark
Sassani, Matilde
Brookes, Matthew
Mahmud, Mohammad
Rayhan, Ray
Jenkinson, Ned
Karavitaki, Niki
Capewell, Nick
Grech, Olivia
Jensen, Ole
Hellyer, Pete
Woodgate, Philip
Coleman, Sebastian
Reynolds, Raymond
Blanch, Richard J.
Morris, Katie
Ottridge, Ryan
Upthegrove, Rachel
Dardis, Ronan
Arachchige, Ruwan Wanni
Berhane, Sarah
Lucas, Sam
Prosser, Sophie
Sharifi, Shayan
Dharm-Datta, Shreshth
Mollan, Susan
Ellmers, Toby
Ghafari, Tara
Goldstone, Tony
Hawa, Waheeda
Gao, Yidian
Blanch, Richard J. http://orcid.org/0000-0002-6142-3280
,
Article History
Received: 30 March 2023
Revised: 20 October 2023
Accepted: 13 November 2023
First Online: 18 January 2024
Competing interests
: SPM reports honoraria for educational events from Heidelberg Engineering during the conduct of the study; She reports advisory board and consultancy fees from Invex Therapeutics and Janssen; honoraria for educational events from Chugai-Roche Ltd, Allergan, Santen, Santhera and Chiesi, all outside the submitted work. AJS reports personal fees from Invex therapeutics in her role as Director with stock holdings, during the conduct of the study; other from Allergan, Novartis, Chiesi and Amgen outside the submitted work. All other authors declare no competing interests. The authors declare no other financial relationships with any organisations that might have an interest in the submitted work; and no other relationships or activities that could appear to have influenced the submitted work.